Jul.21 — Synairgen Plc Chief Executive Officer Richard Marsden discusses the company’s experimental drug which in a clinical trial cut the risk of developing the worst symptoms of Covid-19. Synairgen, a tiny pharmaceutical firm born out of a U.K. university,…